CD44 and cancer: When comparing CD44+ CD24-/low breast cancer stem cells with normal breast epithelium tissue we expect to detect biological processes such as cell motility, cell proliferation, wound healing [36], and extra cellular matrix (ECM) remodeling which are known to be up-regulated in cancer stem cells and are activated in aggressive tumors.